Quantbot Technologies
EVLO

Quantbot Technologies’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History

Quantbot Technologies’s Portfolio EVLO Stock Details EVLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-45
Closed -$3K – 2272
2022
Q1 		$3K Sell
45
-135
-75% -$11.2K ﹤0.01% 1562
2021
Q4 		$21K Buy
+180
New +$30.4K ﹤0.01% 1218

Other funds holding EVLO

Flagship Pioneering
Flagship Pioneering Cambridge, Massachusetts $1.54B AUM 86.39% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.32T AUM 44.66% 1-Year Est. Return
State of Michigan Retirement System
State of Michigan Retirement System Lansing, Michigan $22.6B AUM 32.98% 1-Year Est. Return
Credit Suisse
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Harbourvest Partners
Harbourvest Partners Boston, Massachusetts $170M AUM 34.45% 1-Year Est. Return
CVI Holdings
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Alphabet Inc
Alphabet Inc Mountain View, California $88.3B AUM 46.07% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.92T AUM 36.1% 1-Year Est. Return

Quantbot Technologies's EVLO Position: Q2 2022 in Review

Quantbot Technologies sold out of Evelo Biosciences, Inc. Common Stock (EVLO) in Q2 2022, closing a stake of 45 shares — an estimated $3K sold.

Quantbot Technologies first reported a position in EVLO in Q4 2021 and held it in 2 quarters. The position peaked at $21K in Q4 2021. 46 funds tracked by Wall St. Rank hold EVLO as of Q2 2022.

  • Quantbot Technologies reported no remaining Evelo Biosciences, Inc. Common Stock position as of Q2 2022 after selling out during the quarter.
  • Quantbot Technologies sold 45 Evelo Biosciences, Inc. Common Stock shares in Q2 2022, an estimated $3K.
  • Quantbot Technologies first reported a position in Evelo Biosciences, Inc. Common Stock in Q4 2021 and held it in 2 quarters.
  • Quantbot Technologies's Evelo Biosciences, Inc. Common Stock position peaked at $21K in Q4 2021.
  • 46 funds tracked by Wall St. Rank held Evelo Biosciences, Inc. Common Stock as of Q2 2022.

Based on Quantbot Technologies's 13F filing for Q2 2022, filed 9 Aug 2022.